Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118257 · ClinicalTrials.gov registry record · NA
Short-term Sugary Beverage Consumption on Glucose Control and Cardiovascular Disease Risk Factors
A NA study of Metabolic Syndrome, sponsored by Kansas State University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT04118257: Completed NA study of Metabolic Syndrome, sponsored by Kansas State University.
NCT04118257 is a NA study of Metabolic Syndrome that has completed, run by Kansas State University. The registered enrollment target is 37 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04118257, a NA study of Metabolic Syndrome, has completed, sponsored by Kansas State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
Our goal is to determine how the addition of sugar-sweetened beverages to the diet affects glucose control, cardiovascular disease risk factors, and pulmonary function in healthy, young adults.
Primary Outcome
Glucose obtained from blood sample in a fasted state and in response to a meal
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Control: Water
- DIETARY_SUPPLEMENT Sugary beverage: Fruit juice
- DIETARY_SUPPLEMENT Sugary beverage: Soda
Study Locations (1)
Kansas
- Lafene Health Center - Manhattan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-02-10 |
| Est. Completion | 2018-11-14 |
| Phase | NA |
What the finished NCT04118257 record still lists
NCT04118257 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Control: Water is the first listed.
NCT04118257 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT04118257 about?
NCT04118257 is a clinical study titled "Short-term Sugary Beverage Consumption on Glucose Control and Cardiovascular Disease Risk Factors". Our goal is to determine how the addition of sugar-sweetened beverages to the diet affects glucose control, cardiovascular disease risk factors, and pulmonary function in healthy, young adults.
What is the current status of trial NCT04118257?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-02-10. Estimated completion is 2018-11-14.
What conditions does trial NCT04118257 study?
This clinical trial studies the following conditions: Metabolic Syndrome.
What interventions are being tested in trial NCT04118257?
The interventions under investigation include: Control: Water (DIETARY_SUPPLEMENT), Sugary beverage: Fruit juice (DIETARY_SUPPLEMENT), Sugary beverage: Soda (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04118257?
This trial is sponsored by Kansas State University, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04118257 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04118257's enrollment target sits among peer trials
37 71st of 102 higher than 31 of 102 other Metabolic Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Animal and Plant Proteins and Glucose Metabolism
RECRUITING · NA
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI